{
    "doc_id": "v1_data/Qwen2.5-32B-Instruct_gpqa-diamond_responses_15.json",
    "metadata": {
        "model_id": "Qwen/Qwen2.5-32B-Instruct",
        "correct_answer": "D"
    },
    "raw_text": {
        "question": "How many of the following compounds will exhibit optical activity?\n\n(Z)-1-chloro-2-methylbut-1-ene\n(3aR,7aS,E)-8-(chloromethylene)hexahydro-4,7-methanoisobenzofuran-1,3-dione\n(2R,3S)-2,3-dimethylsuccinic acid\n(2R,3R)-2,3-dimethylsuccinic acid\n(R)-cyclohex-3-en-1-ol\n(1s,3s,5s)-cyclohexane-1,3,5-triol\n1-cyclopentyl-3-methylbutan-1-one\nA. 4\nB. 2\nC. 5\nD. 3",
        "response": "To determine which of these compounds exhibit optical activity, we need to identify if they have chiral centers or chiral axes that can give rise to non-superimposable mirror images (enantiomers).\n\n1. **(Z)-1-chloro-2-methylbut-1-ene**: This compound does not have a chiral center; it is a geometric isomer due to the double bond. It does not exhibit optical activity.\n\n2. **(3aR,7aS,E)-8-(chloromethylene)hexahydro-4,7-methanoisobenzofuran-1,3-dione**: The presence of multiple stereocenters (indicated by R and S configurations) suggests this compound has chiral centers and thus can exhibit optical activity.\n\n3. **(2R,3S)-2,3-dimethylsuccinic acid**: This compound has two chiral centers with different configurations (R and S), indicating it is a chiral molecule and can exhibit optical activity.\n\n4. **(2R,3R)-2,3-dimethylsuccinic acid**: Similar to the previous compound, this one also has two chiral centers but with the same configuration (both R). However, since the configurations are identical, it is not a chiral molecule and does not exhibit optical activity.\n\n5. **(R)-cyclohex-3-en-1-ol**: This compound has a single chiral center (indicated by R), making it a chiral molecule and capable of exhibiting optical activity.\n\n6. **(1s,3s,5s)-cyclohexane-1,3,5-triol**: This compound has three chiral centers, all with the same configuration (all s). Since all chiral centers have the same configuration, the molecule is not chiral and does not exhibit optical activity.\n\n7. **1-cyclopentyl-3-methylbutan-1-one**: This compound does not have any chiral centers, so it does not exhibit optical activity.\n\nSummarizing the analysis:\n- Compounds that exhibit optical activity: (3aR,7aS,E)-8-(chloromethylene)hexahydro-4,7-methanoisobenzofuran-1,3-dione, (2R,3S)-2,3-dimethylsuccinic acid, (R)-cyclohex-3-en-1-ol.\n- Total number of optically active compounds: 3.\n\nTherefore, the correct answer is D. 3."
    },
    "nodes": [
        {
            "id": "ctx0",
            "annotation": false,
            "start": 0,
            "end": 68,
            "label": "context",
            "text": "How many of the following compounds will exhibit optical activity?\n\n",
            "source": "question"
        },
        {
            "id": "ctx1",
            "annotation": false,
            "start": 68,
            "end": 338,
            "label": "context",
            "text": "(Z)-1-chloro-2-methylbut-1-ene\n(3aR,7aS,E)-8-(chloromethylene)hexahydro-4,7-methanoisobenzofuran-1,3-dione\n(2R,3S)-2,3-dimethylsuccinic acid\n(2R,3R)-2,3-dimethylsuccinic acid\n(R)-cyclohex-3-en-1-ol\n(1s,3s,5s)-cyclohexane-1,3,5-triol\n1-cyclopentyl-3-methylbutan-1-one\nA. ",
            "source": "question"
        },
        {
            "id": "ctx2",
            "annotation": false,
            "start": 338,
            "end": 343,
            "label": "context",
            "text": "4\nB. ",
            "source": "question"
        },
        {
            "id": "ctx3",
            "annotation": false,
            "start": 343,
            "end": 354,
            "label": "context",
            "text": "2\nC. 5\nD. 3",
            "source": "question"
        },
        {
            "id": "resp0",
            "annotation": false,
            "start": 0,
            "end": 198,
            "label": "planning",
            "text": "To determine which of these compounds exhibit optical activity, we need to identify if they have chiral centers or chiral axes that can give rise to non-superimposable mirror images (enantiomers).\n\n",
            "source": "response"
        },
        {
            "id": "resp1",
            "annotation": false,
            "start": 198,
            "end": 331,
            "label": "fact",
            "text": "1. **(Z)-1-chloro-2-methylbut-1-ene**: This compound does not have a chiral center; it is a geometric isomer due to the double bond. ",
            "source": "response"
        },
        {
            "id": "resp2",
            "annotation": false,
            "start": 331,
            "end": 370,
            "label": "reasoning",
            "text": "It does not exhibit optical activity.\n\n",
            "source": "response"
        },
        {
            "id": "resp3",
            "annotation": false,
            "start": 370,
            "end": 613,
            "label": "reasoning",
            "text": "2. **(3aR,7aS,E)-8-(chloromethylene)hexahydro-4,7-methanoisobenzofuran-1,3-dione**: The presence of multiple stereocenters (indicated by R and S configurations) suggests this compound has chiral centers and thus can exhibit optical activity.\n\n",
            "source": "response"
        },
        {
            "id": "resp4",
            "annotation": false,
            "start": 613,
            "end": 803,
            "label": "reasoning",
            "text": "3. **(2R,3S)-2,3-dimethylsuccinic acid**: This compound has two chiral centers with different configurations (R and S), indicating it is a chiral molecule and can exhibit optical activity.\n\n",
            "source": "response"
        },
        {
            "id": "resp5",
            "annotation": false,
            "start": 803,
            "end": 958,
            "label": "fact",
            "text": "4. **(2R,3R)-2,3-dimethylsuccinic acid**: Similar to the previous compound, this one also has two chiral centers but with the same configuration (both R). ",
            "source": "response"
        },
        {
            "id": "resp6",
            "annotation": false,
            "start": 958,
            "end": 1075,
            "label": "reasoning",
            "text": "However, since the configurations are identical, it is not a chiral molecule and does not exhibit optical activity.\n\n",
            "source": "response"
        },
        {
            "id": "resp7",
            "annotation": false,
            "start": 1075,
            "end": 1238,
            "label": "reasoning",
            "text": "5. **(R)-cyclohex-3-en-1-ol**: This compound has a single chiral center (indicated by R), making it a chiral molecule and capable of exhibiting optical activity.\n\n",
            "source": "response"
        },
        {
            "id": "resp8",
            "annotation": false,
            "start": 1238,
            "end": 1362,
            "label": "fact",
            "text": "6. **(1s,3s,5s)-cyclohexane-1,3,5-triol**: This compound has three chiral centers, all with the same configuration (all s). ",
            "source": "response"
        },
        {
            "id": "resp9",
            "annotation": false,
            "start": 1362,
            "end": 1483,
            "label": "reasoning",
            "text": "Since all chiral centers have the same configuration, the molecule is not chiral and does not exhibit optical activity.\n\n",
            "source": "response"
        },
        {
            "id": "resp10",
            "annotation": false,
            "start": 1483,
            "end": 1615,
            "label": "reasoning",
            "text": "7. **1-cyclopentyl-3-methylbutan-1-one**: This compound does not have any chiral centers, so it does not exhibit optical activity.\n\n",
            "source": "response"
        },
        {
            "id": "resp11",
            "annotation": false,
            "start": 1615,
            "end": 1820,
            "label": "restatement",
            "text": "Summarizing the analysis:\n- Compounds that exhibit optical activity: (3aR,7aS,E)-8-(chloromethylene)hexahydro-4,7-methanoisobenzofuran-1,3-dione, (2R,3S)-2,3-dimethylsuccinic acid, (R)-cyclohex-3-en-1-ol.\n",
            "source": "response"
        },
        {
            "id": "resp12",
            "annotation": false,
            "start": 1820,
            "end": 1870,
            "label": "restatement",
            "text": "- Total number of optically active compounds: 3.\n\n",
            "source": "response"
        },
        {
            "id": "resp13",
            "annotation": false,
            "start": 1870,
            "end": 1908,
            "label": "conclusion",
            "text": "Therefore, the correct answer is D. 3.",
            "source": "response"
        }
    ],
    "edges": [
        {
            "id": "e0",
            "from_node_id": "resp0",
            "to_node_id": "resp1",
            "label": "reason:plan-step"
        },
        {
            "id": "e1",
            "from_node_id": "resp1",
            "to_node_id": "resp2",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e2",
            "from_node_id": "resp1",
            "to_node_id": "resp3",
            "label": "reason:fact-detail"
        },
        {
            "id": "e3",
            "from_node_id": "resp2",
            "to_node_id": "resp3",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e4",
            "from_node_id": "resp3",
            "to_node_id": "resp4",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e5",
            "from_node_id": "resp4",
            "to_node_id": "resp5",
            "label": "reason:fact-detail"
        },
        {
            "id": "e6",
            "from_node_id": "resp4",
            "to_node_id": "resp6",
            "label": "reason:stmt-correction"
        },
        {
            "id": "e7",
            "from_node_id": "resp5",
            "to_node_id": "resp6",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e8",
            "from_node_id": "resp3",
            "to_node_id": "resp7",
            "label": "reason:fact-detail"
        },
        {
            "id": "e9",
            "from_node_id": "resp4",
            "to_node_id": "resp7",
            "label": "reason:fact-detail"
        },
        {
            "id": "e10",
            "from_node_id": "resp5",
            "to_node_id": "resp7",
            "label": "reason:fact-detail"
        },
        {
            "id": "e11",
            "from_node_id": "resp6",
            "to_node_id": "resp7",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e12",
            "from_node_id": "resp7",
            "to_node_id": "resp8",
            "label": "reason:fact-detail"
        },
        {
            "id": "e13",
            "from_node_id": "resp6",
            "to_node_id": "resp9",
            "label": "reason:concept-example"
        },
        {
            "id": "e14",
            "from_node_id": "resp8",
            "to_node_id": "resp9",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e15",
            "from_node_id": "resp7",
            "to_node_id": "resp10",
            "label": "reason:plan-step"
        },
        {
            "id": "e16",
            "from_node_id": "resp8",
            "to_node_id": "resp10",
            "label": "reason:plan-step"
        },
        {
            "id": "e17",
            "from_node_id": "resp10",
            "to_node_id": "resp10",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e18",
            "from_node_id": "resp3",
            "to_node_id": "resp11",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e19",
            "from_node_id": "resp4",
            "to_node_id": "resp11",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e20",
            "from_node_id": "resp7",
            "to_node_id": "resp11",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e21",
            "from_node_id": "resp11",
            "to_node_id": "resp12",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e22",
            "from_node_id": "resp11",
            "to_node_id": "resp13",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e23",
            "from_node_id": "resp12",
            "to_node_id": "resp13",
            "label": "reason:stmt-restatement"
        }
    ]
}